Cost per median overall month of survival in multiple myeloma patients with $>$= 3 lines of therapy or were double refractory. Maiese, EM, Dimova, M, Baio, G, & Makin, C May, 2016. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
Cost per median overall month of survival in multiple myeloma patients with $>$= 3 lines of therapy or were double refractory. [link]Paper  doi  bibtex   
@misc{Maieseetal:2016,
author = {{Maiese, EM} and Dimova, M and Baio, G and Makin, C},
journal = {Journal of Clinical Oncology},
month = {May},
organization = {Chicago, IL},
publisher = {American Society of Clinical Oncology},
title = {Cost per median overall month of survival in multiple myeloma patients with $>$= 3 lines of therapy or were double refractory.},
url = {https://iris.ucl.ac.uk/iris/publication/1439883/3},
volume = {34},
year = {2016},
doi = {10.1200/JCO.2016.34.15_suppl.8057},
startyear = {2016},
startmonth = {Jun},
startday = {3},
finishyear = {2016},
finishmonth = {Jun},
finishday = {7},
issn = {0732-183X},
eissn = {1527-7755},
issue = {15},
note = {Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)},
organization = {Chicago, IL (US)},
day = {20},
}
Downloads: 0